Human papillomavirus vaccine uptake in South Korea

Jae Hong No,Su Jin Jeong,Miseon Kim,Yong Beom Kim,Kidong Kim,Dong Hoon Suh,Byung-Su Kwon,Jin Young Choi

doi:10.31083/j.ceog4901022

Abstract

Background: This study aimed to assess the human papillomavirus (HPV) vaccine uptake rate in South Korean women and to identify factors affecting vaccination rate before initiation of the national HPV vaccination as a National Immunization Program (NIP) in Korea. Materials and methods: We conducted online survey in February 2016 with questions to 2000 women aged between 9 and 59 years in South Korea by distribution of age and region, to assess HPV uptake and associated correlates such as age, residential region, education, and socioeconomic status. Results: The overall HPV vaccine received at least 1 dose rate was 23.1%, and the highest rate of vaccination was observed in women aged 20–29 years (38.6%), followed by those aged 30–39 years (36.9%), 9–19 years (16.9%), 40–49 years (14.2%), and 50–59 years (12.5%). Factors affecting HPV vaccination included metropolitan cities (odds ratio [OR] = 1.44, 95% confidence interval [CI], 1.15–1.80), university graduate (OR = 1.45, 95% CI, 1.06–2.00), regular influenza vaccination (OR = 2.11, 95% CI, 1.64–2.70), visited clinic within the last 6 months (OR = 1.73, 95% CI, 1.20–2.51) and high family income (OR = 1.55, 95% CI, 1.01–2.37). Conclusion: HPV vaccine uptake is low in South Korean women. Correct publicity, education and economic support programs for HPV vaccine could play an important role in increasing HPV vaccine uptake in South Korea.

Highlights

The fourth most common cancer in worldwide women is cervical cancer which is accounted for 604,127 new cases and 341,831 deaths in 2020 [1]
The human papillomavirus (HPV) vaccine uptake was significantly lower in women aged 9 to years compared to that in women aged to years (16.9% vs. 38.6%, p < 0.001) and to 39 years (16.9% vs. 36.9%, p < 0.001) (Table 1)
Women living in the metropolitan cities were more likely to receive the HPV vaccine than those living in the rural areas (26.2% vs. 20.5%, p = 0.003) (Table 1)

Summary

Introduction

The fourth most common cancer in worldwide women is cervical cancer which is accounted for 604,127 new cases and 341,831 deaths in 2020 [1]. In South Korean women, cervical cancer is eighth most common cancer which is accounted for 3500 new cancers and 845 deaths in 2018 [2]. HPV preventive vaccine has a preventive effect in middle-aged women (27 to 45 years); before vaccination, a clinical assessment of individual patient risk and state of inoculation should be performed [8]. This study aimed to assess the human papillomavirus (HPV) vaccine uptake rate in South Korean women and to identify factors affecting vaccination rate before initiation of the national HPV vaccination as a National Immunization Program (NIP) in Korea. Materials and methods: We conducted online survey in February 2016 with questions to 2000 women aged between 9 and 59 years in South Korea by distribution of age and region, to assess HPV uptake and associated correlates such as age, residential region, education, and socioeconomic status.

Objectives

Methods

Results

Discussion

Conclusion